SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The community is buzzing around ImmunityBio (IBRX) as founder Dr. Patrick Soon-Shiong appears in highly anticipated prime-time interviews to discuss breakthrough cancer treatments, with investors actively debating the potential for a significant short squeeze and an impactful business update next week that could challenge traditional pharma.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is surging following a strong earnings beat and upbeat guidance for AI/data center demand for its 400G and 800G transceivers, alongside significant analyst price target upgrades. The rally is fueled by short-squeeze momentum and optimism for future growth, though community discussion also reflects concerns over the company's valuation and a recent equity offering.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF ($VTI) is generating significant discussion as a bellwether for the U.S. market, with investors observing strong inflows and its proximity to all-time highs. The community is weighing these positive signals against prevailing political and economic uncertainties, prompting ongoing debate about diversification and market direction.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is trending after a substantial earnings and revenue miss, coupled with weak 2026 guidance, has sent the stock plummeting, leading to widespread investor frustration and calls for management accountability. While many fear further downside due to perceived incompetence and potential dilution, a segment of the community views the steep decline as an overreaction, highlighting the company's growing backlog and role in the crucial energy storage market.

Hawaiian Electric Industries, Inc. is a holding company, which engages in electric utility and non-regulated renewable and sustainable infrastructure businesses. The company was founded by C. Dudley Pratt Jr. in 1981 and is headquartered in Honolulu, HI.

Hawaiian Electric Industries, Inc.

Hawaiian Electric is trending as investors assess recent earnings reports and ongoing legislative efforts to cap wildfire liabilities against concerns of significant share dilution and the substantial cost of its $1.99 billion settlement. The community is sharply divided between bulls anticipating a strong recovery fueled by institutional accumulation and bears warning of sustained selling pressure from future capital raises.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is gaining significant attention as its community rallies around the approaching 4/20 festivities, emphasizing its robust culture, unity, and long-term belief, positioning it as a decentralized payment solution for the evolving global cannabis industry.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is a top trending stock after voluntarily pausing its Phase 3 trial for ARD-101 due to cardiac safety signals, sparking widespread investor concern and negative sentiment around its pipeline and competitive position in Prader-Willi Syndrome treatment.

Renaissance Capital Greenwich Funds - Renaissance IPO ETF

The IPO ETF is trending amidst a surge in new offerings, including a diverse range of SPACs, biotechs, and tech firms, sparking active community debate over mixed initial performance and potential market liquidity signals. While some recent debuts have seen significant pops, others have faced substantial deal size reductions, leading to a cautious yet active sentiment among investors.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is trending sharply following the FDA approval of VYKAT XR, the first therapy for Prader-Willi Syndrome, a catalyst amplified by competitor trial failures which is sparking intense community debate over its significant market potential and valuation amid ongoing short-seller challenges.

SSgA Active Trust - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

The Health Care Select Sector SPDR Fund ($XLV) is trending due to significant market rotation into defensive sectors amid broader market volatility, with many observing its strong performance and potential for a breakout to new highs. Simultaneously, President Trump's proposed 100% tariffs on branded pharmaceuticals are a major talking point, raising concerns about potential impacts on drugmakers and supply chains within the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Solar Stocks To Keep An Eye On - February 26th

First Solar, Array Technologies, Nextpower, Sunrun, and Enphase Energy are the five Solar stocks to watch today, according to MarketBeat's stock screener tool. Solar stocks are shares of publicly...

Array Technologies shares declined 23% on Friday to hit over two-year lows

ARRY Stock Cracks 26%, On Track To Hit 200-DMA For First Time In 3 Months – Retail Says Valuation Is ‘Cheap’

Array’s Q4 revenue fell 17% year-on-year to $226 million, while net loss widened to $145.7 million.

ARRY Stock Is On Track To Hit 200-DMA For First Time In 3 Months – Retail Says Valuation Is ‘Cheap’

Equity

Array Tech Stock Nosedives 24% On Q4 Report, Weak Guidance

Here's a look at why Array Technologies stock is plunging after Q4 earnings.read more...

ARRY vs. NXT: Which Solar Tracker Stock Has More Potential?

NXT's surging stock, rising guidance and global expansion sharpen its edge over ARRY in the race to capture booming solar tracker demand.

Shoals Technologies Group (SHLS) Lags Q4 Earnings Estimates

Shoals Technologies (SHLS) delivered earnings and revenue surprises of -27.27% and +2.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

What Should You Do With ARRY Stock Ahead of Q4 Earnings?

ARRY Q4 revenues are expected to decline 23.7%, while earnings are likely to break even. Can backlog strength and solar momentum offset policy headwinds?

Array Technologies Legacy Operations Regain Momentum on Volume Surge?

ARRY's Legacy Operations rebound 87% on a 104% volume jump, driving 81% of 2025 revenues amid strong U.S. solar demand and backlog strength.

SolarEdge Technologies Q4 Earnings Top Estimates, Revenues Rise Y/Y

SEDG narrows its Q4 loss and posts a 70.9% revenue surge, with shipments and cash flow improving.

Array Technologies, Inc. (ARRY) Rises Higher Than Market: Key Facts

In the latest trading session, Array Technologies, Inc. (ARRY) closed at $11.29, marking a +1.16% move from the previous day.

Why R&D Spending Is Central to ARRY's Long-Term Profitability

ARRY is doubling down on R&D to sharpen its solar tracker edge, lift energy yield, cut LCOE and fuel long-term margin expansion. Shares are up 95% in six months.

$ARRY Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$1.06 down -13.98% YoY
• Reported revenue of $226.04M down -17.87% YoY
• ARRAY Technologies guides 2026 revenue to be between $1.4B and $1.5B, with Adjusted EBITDA projected from $200M to $230M, and Adjusted net income per common share from $0.65 to $0.75.

Stocktwits

Array Technologies Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$1.06 down -13.98% YoY
• Reported revenue of $226.04M down -17.87% YoY
• ARRAY Technologies guides 2026 revenue to be between $1.4B and $1.5B, with Adjusted EBITDA projected from $200M to $230M, and Adjusted net income per common share from $0.65 to $0.75.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Array Technologies, Inc. manufactures ground-mounting systems used in solar energy projects. The company sells its products to engineering, procurement and construction firms that build solar energy projects and to large solar developers, independent power producers and utilities, master supply agreements or multi-year procurement contracts. It has offices in Europe, Central America, and Australia. The company's products include DuraTrack and SmarTrack. Array Technologies was founded by Ronald P. Corio in 1989 and is headquartered in Albuquerque, NM.

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$7.58
Prev Close	$7.28
Open	$7.14
Dividend Yield	0.00%
50-Day Moving Average	$10.28
Beta	1.33
Avg. Volume	6.29M
PE Ratio	-9.91

52-Week High	$12.23
52-Week Low	$3.76
Market Capitalization	$1.11B
EPS (Annual)	-$0.7345
Price to Book	-5.39
Revenue Per Employee	$1.07M

ARRY
Array Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARRY News

ARRYArray Technologies Inc